Related Experiment Video
Updated: Jul 14, 2026

Models of Bone Metastasis
Published on: September 4, 2012
Platelet and osteoclast beta3 integrins are critical for bone metastasis
Suzanne J Bakewell1, Patrick Nestor, Srinivasa Prasad
1Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR and Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Abstract:
Mice with a targeted deletion of beta3 integrin were used to examine the process by which tumor cells metastasize and destroy bone. Injection of B16 melanoma cells into the left cardiac ventricle resulted in osteolytic bone metastasis in 74% of beta3+/+ mice by 14 days. In contrast, only 4% of beta3-/- mice developed bone lesions. Direct intratibial inoculation of tumor resulted in marrow replacement by tumor in beta3-/- mice, but no associated trabecular bone resorption as seen inbeta3+/+ mice. Bone marrow transplantation studies showed that susceptibility to bone metastasis was conferred by a bone marrow-derived cell. To dissect the roles of osteoclast and platelet beta3 integrins in this model of bone metastasis, osteoclast-defective src-/- mice were used. Src-null mice were protected from tumor-associated bone destruction but were not protected from tumor cell metastasis to bone. In contrast, a highly specific platelet aggregation inhibitor of activated alphaIIbbeta3 prevented B16 metastases. These data demonstrate a critical role for platelet alphaIIbbeta3 in tumor entry into bone and suggest a mechanism by which antiplatelet therapy may be beneficial in preventing the metastasis of solid tumors.
Insights
Platelet integrin alphaIIbbeta3 is critical for tumor cells entering bone and causing osteolytic metastasis. Inhibiting this integrin may prevent solid tumor spread and bone destruction.
Area of Science:
- Oncology
- Integrin Biology
- Bone Metastasis Research
Background:
- Tumor metastasis to bone is a significant cause of morbidity.
- Integrins play roles in cell adhesion and migration, crucial for metastasis.
- The specific role of beta3 integrin in bone metastasis and destruction is not fully understood.
Purpose of the Study:
- To investigate the role of beta3 integrin in tumor cell metastasis to bone.
- To determine the contribution of beta3 integrin in osteolytic bone destruction.
- To elucidate the specific cellular sources (osteoclasts vs. platelets) of beta3 integrin involved in bone metastasis.
Main Methods:
- Utilized beta3 integrin knockout (beta3-/-) mice and wild-type (beta3+/+) littermates.
- Administered B16 melanoma cells via cardiac ventricle injection and intratibial inoculation.
- Employed bone marrow transplantation studies and osteoclast-defective src-/- mice.
- Tested the effect of a specific alphaIIbbeta3 platelet aggregation inhibitor.
Main Results:
- Beta3 integrin deletion significantly reduced osteolytic bone metastasis following intravenous tumor cell injection.
- Intratibial tumor inoculation in beta3-/- mice showed tumor growth without bone resorption.
- Src-null mice were protected from bone destruction but not metastasis, indicating osteoclasts are key to destruction, not entry.
- Platelet alphaIIbbeta3 inhibition effectively prevented tumor metastasis to bone.
Conclusions:
- Platelet alphaIIbbeta3 integrin is essential for tumor cell entry into bone, driving metastasis.
- Osteoclast beta3 integrin is critical for tumor-induced bone resorption but not for initial tumor cell homing to bone.
- Targeting platelet alphaIIbbeta3 represents a potential therapeutic strategy to prevent solid tumor metastasis to bone.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
Selectins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

